Feb 24, 2026Alcohol, Aging, and Long-Term Health: What the Evidence ShowsAlcohol consumption interacts with aging biology in complex ways. This article covers the liver, brain, cardiovascular, and cancer evidence, plus what nutritional strategies can mitigate harm.
Feb 19, 2026Lion's Mane and Cognitive Function: Mechanisms, Human Evidence, and ProtocolLion's Mane mushroom stimulates nerve growth factor production and has shown cognitive benefits in small randomized trials in older adults, with preclinical evidence stronger than human data.
Feb 18, 2026Depression and Mood Decline in Aging: Evidence-Based ApproachesLate-life depression is underdiagnosed and undertreated. This article covers the neurobiological drivers of mood decline in aging and the best-evidenced interventions.
Feb 17, 2026Alzheimer's and Dementia Prevention: What the Evidence SaysCognitive decline is not inevitable. This protocol reviews the strongest modifiable risk factors and evidence-based interventions for reducing Alzheimer's and dementia risk.
Feb 16, 2026Phosphatidylcholine: Liver Health, Cognitive Aging, and Choline AdequacyPhosphatidylcholine is the dominant structural phospholipid in cell membranes and a major dietary choline source. It supports liver fat export, membrane integrity, and acetylcholine synthesis. Most adults are choline-insufficient; supplementation has meaningful implications for liver and brain aging.
Feb 15, 2026Magnesium L-Threonate: Brain Penetration, Synaptic Density, and Cognitive EvidenceMagnesium L-threonate (MgT) was developed specifically to cross the blood-brain barrier more effectively than other magnesium forms. Animal studies show increased synaptic density and memory improvement. Human trials are limited but show working memory and executive function benefits in older adults.
Feb 14, 2026Carnosine: Glycation Buffering, Brain Aging, and Carnosinase VariabilityCarnosine is a dipeptide that buffers glycation and carbonyl stress, with additional evidence for neuroprotection. Oral carnosine is cleaved by carnosinase — tissue uptake varies significantly by carnosinase genotype, which affects individual response.
Feb 3, 2026Magnesium L-Threonate and Brain Health: Evidence from Human TrialsMagnesium L-threonate was developed to improve brain magnesium delivery. Human trials show modest cognitive improvements in older adults, though sample sizes are small and independent replication is limited.
Jan 28, 2026Cognitive Decline Prevention: 12 Evidence-Based Domains and the FINGER Trial FrameworkThe FINGER trial demonstrated that a multimodal intervention (diet, exercise, cognitive training, vascular monitoring) significantly slowed cognitive decline. This article maps 12 modifiable domains and the supplements with strongest supporting evidence.
Jan 23, 2026Bacopa Monnieri and Memory: Bacosides, Cognitive Aging, and 12-Week RCT EvidenceBacopa monnieri improves memory consolidation and information processing in older adults. Consistent effects require 8-12 weeks of daily use. Bacosides A and B are the primary active compounds. GI side effects occur at higher doses.
Jan 13, 2026Phosphatidylserine for Cognitive Aging: Memory Decline, Evidence Grade, and PS+DHA SynergyPhosphatidylserine has FDA-qualified health claim status for cognitive aging. Older trials with bovine-derived PS showed consistent memory benefits; soy-derived PS effects are smaller but still meaningful.